SMS Pharmaceuticals announced that it has successfully completed a US Food and Drug Administration (USFDA) inspection at its Active Pharmaceutical Ingredient (API) manufacturing facility located in Bachupally, Hyderabad, Telangana.
More NewsSELECT INDEX : March 21, 2025
HIGH
77,041.94() |
LOW
76,095.26() |
PREVIOUS
76,348.06() |
GIFT Nifty signals a negative opening
March 21, 2025 8:23 AM